{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:38:16Z","timestamp":1793299096379,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.semnephrol.2010.10.007","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T04:04:15Z","timestamp":1295841855000},"page":"70-85","source":"Crossref","is-referenced-by-count":65,"title":["Antihypertensive Drugs in Pregnancy"],"prefix":"10.1016","volume":"31","author":[{"given":"Tiina","family":"Podymow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis","family":"August","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2010.10.007_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"High blood pressure in pregnancy","volume":"183","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0029-7844(95)00480-7","article-title":"Maternal hypertension and associated pregnancy complications among African-American and other women in the United States","volume":"87","author":"Samadi","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/sper.2001.24903","article-title":"Antihypertensive drugs during pregnancy","volume":"25","author":"Sibai","year":"2001","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib4","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002252.pub2","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"1","author":"Abalos","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.293.1.77","article-title":"Urinary placental growth factor and risk of preeclampsia","volume":"293","author":"Levine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bpobgyn.2007.11.004","article-title":"Maternal deaths due to hypertensive disorders in pregnancy","volume":"22","author":"Moodley","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0029-7844(02)02128-2","article-title":"Chronic hypertension in pregnancy","volume":"100","author":"Sibai","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/10641950601147952","article-title":"Predicting transformation from gestational hypertension to preeclampsia in clinical practice: a possible role for 24 hour ambulatory blood pressure monitoring","volume":"26","author":"Davis","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1067\/mob.2001.112905","article-title":"Mild gestational hypertension remote from term: progression and outcome","volume":"184","author":"Barton","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5694\/j.1326-5377.1996.tb125017.x","article-title":"Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features","volume":"165","author":"Brown","year":"1996","journal-title":"Med J Aust"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.grf.0000160311.74983.28","article-title":"Antihypertensive medications in management of gestational hypertension-preeclampsia","volume":"48","author":"von Dadelszen","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"1","author":"Abalos","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib15","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/bmj.318.7194.1332","article-title":"Fortnightly review: management of hypertension in pregnancy","volume":"318","author":"Magee","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis","volume":"355","author":"von Dadelszen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib17","first-page":"715","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 1","volume":"157","author":"Helewa","year":"1997","journal-title":"CMAJ"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2010.10.007_bib18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32776-1","article-title":"Diagnosis, evaluation, and management of thehypertensive disorders of pregnancy","volume":"30","author":"Magee","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1479-828X.2000.tb01137.x","article-title":"The detection, investigation and management of hypertension in pregnancy: full consensus statement","volume":"40","author":"Brown","year":"2000","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.AOG.0000151116.84113.56","article-title":"Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure","volume":"105","author":"Martin","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib21","doi-asserted-by":"crossref","first-page":"514.e1","DOI":"10.1016\/j.ajog.2007.02.021","article-title":"Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications","volume":"196","author":"Sibai","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1471-0528.2005.00614.x","article-title":"Morbidity and development in childhood of infants born after temporising treatment of early onset pre-eclampsia","volume":"112","author":"Withagen","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/beog.2001.0232","article-title":"Drugs in pregnancy","volume":"15","author":"Magee","year":"2001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib24","first-page":"1245","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 3","volume":"157","author":"Rey","year":"1997","journal-title":"CMAJ"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001449.pub2","article-title":"Drugs for treatment of very high blood pressure during pregnancy","volume":"3","author":"Duley","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib27","series-title":"Medical Disorders During Pregnancy","author":"Lindheimer","year":"2000"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/tera.1420490603","article-title":"Teratology Society Public Affairs Committee","volume":"49","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.ackd.2007.01.009","article-title":"Medications during pregnancy: antihypertensives and immunosuppressives","volume":"14","author":"Umans","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(76)90597-3","article-title":"Fetal outcome in trial of antihypertensive treatment in pregnancy","volume":"2","author":"Redman","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib31","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0002-9378(90)91297-P","article-title":"A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy","volume":"162","author":"Sibai","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0140-6736(68)90650-8","article-title":"A controlled trial of hypotensive agents in hypertension in pregnancy","volume":"2","author":"Leather","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib33","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/bmj.286.6382.1927","article-title":"Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy","volume":"286","author":"Fidler","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bmj.291.6495.563","article-title":"Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa","volume":"291","author":"Gallery","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1471-0528.1988.tb06571.x","article-title":"Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial","volume":"95","author":"Plouin","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-0528.1977.tb12616.x","article-title":"Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects","volume":"84","author":"Redman","year":"1977","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9378(12)90905-9","article-title":"Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension","volume":"168","author":"Montan","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-3782(77)90029-9","article-title":"Hypertension during pregnancy, with and without specific hypotensive treatment","volume":"1","author":"Mutch","year":"1977","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0378-3782(77)90030-5","article-title":"Hypertension during pregnancy, with and without specific hypotensive treatment","volume":"1","author":"Mutch","year":"1977","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(82)92202-4","article-title":"Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children","volume":"1","author":"Cockburn","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib41","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0016-5085(74)80013-2","article-title":"Acute submassive hepatic necrosis due to methyldopa","volume":"66","author":"Schweitzer","year":"1974","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib42","first-page":"634","article-title":"Clonidine hydrochloride\u2014a safe and effective antihypertensive agent in pregnancy","volume":"66","author":"Horvath","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-3782(86)90168-4","article-title":"Is clonidine a behavioural teratogen in the human?","volume":"14","author":"Huisjes","year":"1986","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib44","first-page":"431","article-title":"Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension","volume":"1","author":"Rubin","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib45","first-page":"119","article-title":"Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension","volume":"33","author":"Paran","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib46","article-title":"Oral beta-blockers for mild to moderate hypertension during pregnancy","volume":"4","author":"Magee","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.301.6752.587","article-title":"Atenolol in essential hypertension during pregnancy","volume":"301","author":"Butters","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib48","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0002-9149(97)00163-X","article-title":"Effect of atenolol on birth weight","volume":"79","author":"Lip","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0301-2115(99)00113-X","article-title":"Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials","volume":"88","author":"Magee","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/PRG-120028291","article-title":"Do commonly used oral antihypertensives alter fetal or neonatal heart rate characteristics?","volume":"23","author":"Waterman","year":"2004","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib51","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/adc.59.11.1061","article-title":"First year of life after the use of atenolol in pregnancy associated hypertension","volume":"59","author":"Reynolds","year":"1984","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1471-0528.1989.tb01574.x","article-title":"The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension","volume":"96","author":"Pickles","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib53","first-page":"323","article-title":"A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term","volume":"70","author":"Sibai","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib54","first-page":"1507","article-title":"Effects of maternal labetalol on the newborn infant","volume":"29","author":"Munshi","year":"1992","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib55","first-page":"1148","article-title":"Pheochromocytoma and pregnancy: the epitome of high risk","volume":"114","author":"Freier","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib56","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1445-5994.2006.01132.x","article-title":"Phaeochromocytoma in pregnancy","volume":"36","author":"Grodski","year":"2006","journal-title":"Intern Med J"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib57","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9378(96)70307-1","article-title":"The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study","volume":"174","author":"Magee","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1471-0528.2006.01200.x","article-title":"Nicardipine in pre-eclamptic patients: placental transfer and disposition in breast milk","volume":"114","author":"Bartels","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib59","first-page":"354","article-title":"Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial","volume":"84","author":"Jannet","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib60","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0002-9378(95)90357-7","article-title":"Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study","volume":"173","author":"Wide-Swensson","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib61","first-page":"378","article-title":"Felodipine use in pregnancy","volume":"42","author":"Casele","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib62","first-page":"970","article-title":"Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension","volume":"75","author":"Belfort","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10641950701204554","article-title":"Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding","volume":"26","author":"Ahn","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0301-2115(00)00548-0","article-title":"Calcium channel blockers in the management of preterm labor and hypertension in pregnancy","volume":"97","author":"Papatsonis","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib65","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1471-0528.1988.tb06818.x","article-title":"The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy","volume":"95","author":"Lindow","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000298796","article-title":"Effects of nifedipine on umbilical artery velocity waveforms in healthy human fetuses","volume":"24","author":"Rizzo","year":"1987","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib67","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib68","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1471-0528.1993.tb15120.x","article-title":"Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks","volume":"100","author":"Impey","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib69","first-page":"192","article-title":"The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension","volume":"79","author":"Puzey","year":"1991","journal-title":"S Afr Med J"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib70","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1067\/mob.2002.126294","article-title":"Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy","volume":"187","author":"Brown","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib71","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0002-9378(90)90867-7","article-title":"Magnesium plus nifedipine","volume":"162","author":"Ales","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0002-9378(88)80072-3","article-title":"Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia?","volume":"159","author":"Waisman","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib73","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1471-0528.1994.tb13126.x","article-title":"The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade","volume":"101","author":"Ben-Ami","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib74","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate?","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib75","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9378(96)70143-6","article-title":"Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies","volume":"175","author":"Scardo","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib76","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ajog.2004.11.059","article-title":"Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia","volume":"193","author":"Magee","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.290.6461.17","article-title":"Overview of randomised trials of diuretics in pregnancy","volume":"290","author":"Collins","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib78","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/0002-9378(95)90549-9","article-title":"Spironolactone therapy during human pregnancy","volume":"172","author":"Groves","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0301-2115(00)00368-7","article-title":"Pharmacological treatment of severe hypertension in pregnancy and the role of serotonin(2)-receptor blockers","volume":"95","author":"Bolte","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib80","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00006254-200009000-00024","article-title":"Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin","volume":"55","author":"Steyn","year":"2000","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib81","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJM198011203032112","article-title":"Hydralazine-induced neonatal thrombocytopenia","volume":"303","author":"Widerlov","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib82","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0195-668X(03)00098-8","article-title":"Expert consensus document on management of cardiovascular diseases during pregnancy","volume":"24","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib83","first-page":"328","article-title":"A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy","volume":"70","author":"Mabie","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib84","first-page":"331","article-title":"Nifedipine in the treatment of severe preeclampsia","volume":"77","author":"Fenakel","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib85","first-page":"519","article-title":"Effect of dihydralazine on the fetus in the treatment of maternal hypertension","volume":"55","author":"Vink","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib86","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1067\/mob.2003.300","article-title":"The effect of isosorbide dinitrate, a donor of nitric oxide, on maternal cerebral blood flow in gestational hypertension and preeclampsia","volume":"188","author":"Nevo","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib87","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9378(84)90192-3","article-title":"Sodium nitroprusside for control of severe hypertensive disease of pregnancy: a case report and discussion of potential toxicity","volume":"149","author":"Shoemaker","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.HYP.18.1.79","article-title":"Nitroprusside in preeclampsia","volume":"18","author":"Wasserstrum","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib89","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1590\/S1516-31802007000200008","article-title":"Does sodium nitroprusside kill babies?","volume":"125","author":"Sass","year":"2007","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib90","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1681\/ASN.V391575","article-title":"Angiotensin-converting enzyme inhibitor fetopathy","volume":"3","author":"Pryde","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1006822911586","article-title":"An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development","volume":"176","author":"Buttar","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib92","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1345\/aph.1A013","article-title":"Fatal fetal outcome with the combined use of valsartan and atenolol","volume":"35","author":"Briggs","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib93","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0140-6736(00)04757-7","article-title":"Angiotensin-II-receptor inhibitors in pregnancy","volume":"357","author":"Lambot","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib94","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(00)03648-5","article-title":"Losartan and fetal toxic effects","volume":"357","author":"Saji","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib95","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib96","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00228-009-0620-0","article-title":"Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants","volume":"65","author":"Lennestal","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib97","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1042\/cs0710589","article-title":"Blood pressure in the puerperium","volume":"71","author":"Walters","year":"1986","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004351.pub2","article-title":"Prevention and treatment of postpartum hypertension","volume":"1","author":"Magee","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib99","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-0528.2002.01012.x","article-title":"The management of postpartum hypertension","volume":"109","author":"Tan","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/10641950902777747","article-title":"Postpartum course of gestational hypertension and preeclampsia","volume":"29","author":"Podymow","year":"2010","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1081\/PRG-120002912","article-title":"Excretion of antihypertensive medication into human breast milk: a systematic review","volume":"21","author":"Beardmore","year":"2002","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.AOG.0000148270.53433.66","article-title":"Postpartum preeclampsia management with furosemide: a randomized clinical trial","volume":"105","author":"Ascarelli","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib103","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ajog.2003.08.030","article-title":"Postpartum hypertension and nonsteroidal analgesia","volume":"190","author":"Makris","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib104","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00003088-198814040-00003","article-title":"Drugs in human milk","volume":"14","author":"Atkinson","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/089033449701300219","article-title":"Principles of drug transfer into breast milk and drug disposition in the nursing infant","volume":"13","author":"Breitzka","year":"1997","journal-title":"J Hum Lact"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib106","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1517\/14740338.4.4.745","article-title":"Drug use and breastfeeding","volume":"4","author":"Ilett","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib107","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3476(05)81674-9","article-title":"Concentrations of beta-blocking drugs in human milk","volume":"116","author":"Atkinson","year":"1990","journal-title":"J Pediatr"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib108","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.HYP.6.3.297","article-title":"Management of hypertension during lactation","volume":"6","author":"White","year":"1984","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib109","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(89)80579-7","article-title":"Nifedipine transfer into human milk","volume":"114","author":"Ehrenkranz","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/089033440001600213","article-title":"Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) and lactation: an update","volume":"16","author":"Shannon","year":"2000","journal-title":"J Hum Lact"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib111","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib112","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0301-2115(00)00331-6","article-title":"The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy","volume":"94","author":"Magee","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.semnephrol.2010.10.007_bib113","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/HYPERTENSIONAHA.106.075895","article-title":"Update on the use of antihypertensive drugs in pregnancy","volume":"51","author":"Podymow","year":"2008","journal-title":"Hypertension"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929510001774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929510001774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T18:48:24Z","timestamp":1637174904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929510001774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0270929510001774"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2010.10.007","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}